Progenitor cell release plus exercise to improve functional performance in peripheral artery disease: the PROPEL...

Area of Science:

• Cardiovascular Medicine
• Regenerative Medicine
• Clinical Trials

Background:

• Peripheral artery disease (PAD) significantly impairs lower extremity function, leading to mobility loss.
• Current medical therapies offer limited improvement in walking performance for PAD patients.
• Developing effective interventions to enhance walking capacity is a critical public health need.

Purpose of the Study:

• To evaluate the efficacy of granulocyte-macrophage colony stimulating factor (GM-CSF) combined with supervised treadmill exercise in improving walking performance in PAD.
• To compare the combined therapy against GM-CSF alone, exercise alone, and placebo control.
• To investigate the underlying mechanisms of improved function through secondary outcome measures.

Main Methods:

• The PROgenitor cell release Plus Exercise to improve functionaL performance in PAD (PROPEL) Study is a randomized controlled trial with a 2x2 factorial design.
• Participants are randomized into four arms: GM-CSF + exercise, GM-CSF + attention control, placebo + exercise, or placebo + attention control.
• The primary outcome is the change in six-minute walk distance at 12 weeks, with secondary outcomes including flow-mediated dilation, maximal treadmill time, and CD34+ cell counts.

Main Results:

• The study is designed to determine the effectiveness of GM-CSF and exercise interventions.
• Primary endpoint is the change in six-minute walk distance at 12-week follow-up.
• Secondary endpoints include changes in brachial artery flow-mediated dilation, maximal treadmill walking time, and circulating CD34+ cells.

Conclusions:

• The PROPEL Study results will provide crucial insights into effective strategies for enhancing walking performance in PAD.
• Findings are expected to inform the development of novel therapeutic approaches to combat mobility loss in PAD patients.
• Understanding the mechanisms behind functional improvement will aid in preventing disability in the growing PAD population.